Sandip Patel, MD, and Geoffrey R. Oxnard, MD, discuss differences among platforms for genetic profiling of metastatic non–small cell lung cancer in terms of sensitivity, specificity, and multiplex capability, as well as detection of complex genomic alterations.
Good things come in small packages: roles of exosomes as therapy delivery tools, therapeutic targets and potential biomarkers
March 23, 2021
December 3, 2020
Uncovering the Heterogeneity of Extracellular Vesicles Derived From Amniotic Epithelial Cells Associated With Pregnancy Complications and Culture Conditions
November 10, 2020
October 26, 2020
July 20, 2020